Core Insights - The financing balance of the Sci-Tech Innovation Board increased by 1.9 billion yuan compared to the previous trading day, marking a continuous increase for 33 trading days [1] - The total margin balance reached 218 billion yuan, with a financing balance of 217.25 billion yuan and a securities lending balance of 755 million yuan [1] - The stocks with the highest financing balances include SMIC at 11 billion yuan, followed by Cambrian and Haiguang Information at 9.2 billion yuan and 7.2 billion yuan respectively [1] Financing Balance Summary - 270 stocks saw an increase in financing balance, while 314 stocks experienced a decrease [1] - Notable increases in financing balance were observed in Maide Medical (41.95%), Jingyi Equipment (32.05%), and Anbotong (28.86%) [1][2] - Significant decreases were noted in Yifang Bio (-29.85%), Kangwei Century (-21.02%), and Jushi Chemical (-20.70%) [1][2] Securities Lending Balance Summary - The highest securities lending balance was recorded for Cambrian at 48 million yuan, followed by Haiguang Information and SMIC at 39 million yuan and 32 million yuan respectively [2] - 117 stocks saw an increase in securities lending balance, while 158 stocks experienced a decrease [2] - The largest increases in securities lending balance were in Bairen Medical (299.55%), Jucheng Technology (127.31%), and Yihua Tong (112.52%) [2] - The largest decreases were in Tianzhihang (-54.20%), Diaomicro (-50.23%), and Funeng Technology (-46.69%) [2]

Core Viewpoint - The stock of Maide Medical (688310) has experienced a significant decline, with a closing price of 19.23 yuan on August 27, 2025, down 6.24% from the previous day, indicating a volatile trading environment and mixed investor sentiment [1] Financial Performance - For the first half of 2025, Maide Medical reported a main revenue of 141 million yuan, a year-on-year decrease of 14.75% - The net profit attributable to shareholders was 6.0451 million yuan, down 38.81% year-on-year - The net profit after deducting non-recurring items was -2.5149 million yuan, a decline of 135.52% year-on-year [5] Quarterly Performance - In Q2 2025, the company achieved a single-quarter main revenue of 101 million yuan, an increase of 10.58% year-on-year - The single-quarter net profit attributable to shareholders was 16.8424 million yuan, a substantial increase of 2759.64% year-on-year - The single-quarter net profit after deducting non-recurring items was 11.8767 million yuan, up 923.08% year-on-year [5] Market Position - Maide Medical's total market capitalization is 3.196 billion yuan, significantly lower than the industry average of 7.605 billion yuan, ranking 197 out of 265 in the specialized equipment industry - The company's net assets stand at 828 million yuan, compared to the industry average of 2.252 billion yuan, ranking 198 out of 265 [5] Key Financial Ratios - The price-to-earnings (P/E) ratio is 264.38, much higher than the industry average of 72.24, ranking 185 out of 265 - The price-to-book (P/B) ratio is 3.99, slightly above the industry average of 3.84, ranking 152 out of 265 - The gross margin is 38.93%, significantly higher than the industry average of 27.5%, ranking 41 out of 265 - The net margin is -1.29%, worse than the industry average of -0.41%, ranking 209 out of 265 - Return on equity (ROE) is 0.76%, lower than the industry average of 1.76%, ranking 177 out of 265 [5] Trading Activity - On August 27, 2025, the stock had a trading volume of 144,700 hands and a total transaction amount of 289 million yuan - The net inflow of main funds was 13.4688 million yuan, accounting for 4.67% of the total transaction amount, while retail investors saw a net outflow of 1.4399 million yuan, representing 0.5% of the total transaction amount [1][2] Margin Trading - On August 27, 2025, the margin trading data showed a financing balance of 102 million yuan, with a net financing purchase of 30.2464 million yuan - There were no short sales or repayments recorded, indicating a stable margin trading environment [3]

证券日报网讯 8月27日晚间，迈得医疗发布公告称，公司第五届董事会第三次会议审议通过了《关于公 司2025年半年度报告及摘要的议案》等多项议案。 （文章来源：证券日报） ...

Group 1 - The company announced the approval of its 2025 semi-annual report and summary by the third meeting of the fifth supervisory board [1] - The company also approved a special report on the storage and actual use of raised funds for the first half of 2025 [1]

Core Viewpoint - The company reported a decline in both revenue and net profit for the first half of 2025, indicating potential challenges in its financial performance [1] Financial Performance - The company achieved operating revenue of 141 million yuan, a year-on-year decrease of 14.75% [1] - The net profit attributable to shareholders was 6.0451 million yuan, down 38.81% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -2.5149 million yuan, representing a year-on-year decline of 135.52% [1] - Basic earnings per share were reported at 0.04 yuan [1]

Meeting Overview - The third meeting of the fifth Supervisory Board of Maide Medical Industrial Equipment Co., Ltd. was held on August 26, 2025, in the company meeting room, presided over by Chairman Wu Jiangping [1] - The meeting was attended by 3 supervisors, in compliance with the company's articles of association [1] Resolutions Passed - The Supervisory Board approved the proposal regarding the company's 2025 semi-annual report and summary, with a unanimous vote of 3 in favor [2] - The Supervisory Board also approved the special report on the storage and actual use of the company's fundraising for the first half of 2025, also with a unanimous vote of 3 in favor [2]

每经AI快讯，迈得医疗8月27日晚间发布半年度业绩报告称，2025年上半年营业收入约1.41亿元，同比 减少14.75%；归属于上市公司股东的净利润约605万元，同比减少38.81%；基本每股收益0.04元，同比 减少33.33%。 免责声明：本文内容与数据仅供参考，不构成投资建议，使用前请核实。据此操作，风险自担。 每日经济新闻 每经头条（nbdtoutiao）——能给主人"打电话"的宠物智能手机也来了！宠物产业3000亿元市场大爆 发，行业上市公司"涨"声一片 （记者 王晓波） ...

每经头条（nbdtoutiao）——能给主人"打电话"的宠物智能手机也来了！宠物产业3000亿元市场大爆 发，行业上市公司"涨"声一片 每日经济新闻 （记者 王可然） 每经AI快讯，迈得医疗8月27日晚间发布公告称，公司第五届第三次董事会会议于2025年8月26日在公 司会议室召开。会议审议了《关于公司2025年度提质增效重回报专项行动方案的半年度评估报告的议 案》等文件。 免责声明：本文内容与数据仅供参考，不构成投资建议，使用前请核实。据此操作，风险自担。 ...

Maider Da 2025 迈得医疗半年度报告 LEADER IN MEDICAL PRODUCTS AUTOMATION 医用耗材自动化领先者 迈得医疗工业设备股份有限公司2025 年半年度报告 重要提示 一、 本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确 性、完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 重大风险提示 公司已在本报告中详细阐述经营过程中可能面临的风险及应对措施，有关内容敬请查阅第三 节"管理层讨论与分析"之"四、风险因素"。敬请投资者予以关注，审慎作出投资决定。 三、 公司全体董事出席董事会会议。 九、 是否存在被控股股东及其他关联方非经营性占用资金情况 否 四、 本半年度报告未经审计。 五、 公司负责人林军华、主管会计工作负责人林君辉及会计机构负责人（会计主管人员）林君 辉声明：保证半年度报告中财务报告的真实、准确、完整。 六、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 无 七、 是否存在公司治理特殊安排等重要事项 □适用 √不适用 八、 前瞻性陈述的风险声明 √适用 □不适用 本报告中所涉及的未来计 ...

证券代码：688310 证券简称：迈得医疗 公告编号：2025-034 迈得医疗工业设备股份有限公司 2025年半年度募集资金存放与实际使用情况的专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、募集资金基本情况 （一）实际募集资金金额、资金到账时间 根据中国证券监督管理委员会《关于同意迈得医疗工业设备股份有限公司首 次公开发行股票注册的批复》（证监许可〔2019〕2019 号），中国证券监督管理 委员会同意公司首次公开发行股票的注册申请。公司于 2019 年 11 月首次公开发 行人民币普通股（A 股）股票 2,090 万股，每股面值人民币 1.00 元，每股发行价 格 24.79 元，募集资金总额为人民币 51,811.10 万元，扣除发行费用人民币 6,075.96 万元（不含税）后，募集资金净额为人民币 45,735.14 万元。该募集资金已于 2019 年 11 月 26 日到位。天健会计师事务所（特殊普通合伙）对公司本次公开发行新 股的资金到位情况进行了审验，并出具了天健验〔2019〕413 号《验 ...